Cleidson de Pádua Alves

Graduated in Biological Sciences - UNIARAXÁ (2005) and Ph.D. in Cellular and Molecular Biology by the University of Sao Paulo (USP). Worked as a research scientist at Harvard University (2012-2015), University of Oxford (2016-2017), and University of Köln (2017-2020) with focus in molecular oncology. Currently is a Senior Clinical Biomarker lead at Boehringer Ingelheim, in Germany. Has broad experience Biochemistry, Molecular Biology, cell signaling, tumor heterogeneity, tumor cell plasticity and tumor cell dormancy. (Source: Lattes Curriculum)